Funds holding Kyverna Therapeutics Inc
ISIN US5019761049 · United States
- Fund holders
- 42
- Of which ETFs
- 10 32 other funds
- Value held
- 38.1M $
- Share of capital
- 7.2 % of 61.8M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,347,397 | 11.6M $ | 0.00 % | 2.18 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,142,161 | 9.9M $ | 0.09 % | 1.85 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 396,545 | 3.4M $ | 0.00 % | 0.64 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 251,263 | 2.2M $ | 0.03 % | 0.41 % | as of Mar 31, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 173,106 | 1.5M $ | 2.15 % | 0.28 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 117,968 | 968.5K $ | 0.00 % | 0.19 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 112,000 | 966.6K $ | 1.13 % | 0.18 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 110,930 | 910.7K $ | 0.00 % | 0.18 % | as of Feb 28, 2026 ↗ |
| WesMark Small Company Fund WesMark Funds | 110,300 | 951.9K $ | 0.61 % | 0.18 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 96,440 | 832.3K $ | 0.07 % | 0.16 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 80,673 | 696.2K $ | 0.11 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 49,874 | 409.5K $ | 0.02 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 40,308 | 330.9K $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 32,275 | 265K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 32,113 | 277.1K $ | 0.12 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 31,843 | 261.4K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 31,215 | 274.7K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 29,000 | 250.3K $ | 0.20 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 25,000 | 220K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 22,961 | 198.2K $ | 0.12 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 22,459 | 193.8K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 18,317 | 161.2K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 18,022 | 158.6K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 16,941 | 146.2K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 16,677 | 143.9K $ | 0.01 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 15,873 | 139.7K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 15,000 | 123.2K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 12,326 | 108.5K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Managed Volatility Fund II Federated Hermes Insurance Series | 12,000 | 103.6K $ | 0.06 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 8,808 | 76K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Prudent Bear Fund Federated Hermes Equity Funds | 8,000 | 69K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 6,815 | 58.8K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 5,350 | 47.1K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 4,410 | 38.8K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 4,308 | 37.9K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 3,778 | 33.2K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 3,361 | 27.6K $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 2,433 | 20K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,023 | 16.6K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 800 | 6.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 787 | 6.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 235 | 2.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 2.15 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 1.13 % | as of Mar 31, 2026 ↗ |
| WesMark Small Company Fund WesMark Funds | 0.61 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.20 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.12 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 0.12 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 0.11 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 0.09 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Prudent Bear Fund Federated Hermes Equity Funds | 0.07 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.07 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 42 | +5 | 4,432,095 | +5.4 % |
| 2026Q1 | 37 | +1 | 4,204,267 | +27.2 % |
| 2025Q4 | 36 | -20 | 3,305,188 | -17.0 % |
| 2025Q3 | 56 | -41 | 3,981,980 | -6.1 % |
| 2025Q2 | 97 | -5 | 4,241,231 | -23.3 % |
| 2025Q1 | 102 | +2 | 5,528,328 | +18.3 % |
| 2024Q4 | 100 | +37 | 4,673,250 | +13.4 % |
| 2024Q3 | 63 | -3 | 4,121,201 | +36.2 % |
| 2024Q2 | 66 | 3,026,876 |
Institutional managers
107 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| GordonMD Global Investments LP | 4,244,818 | 36.6M $ | as of Mar 31, 2026 |
| GILEAD SCIENCES, INC. | 4,126,119 | 35.6M $ | as of Mar 31, 2026 |
| Bain Capital Life Sciences Investors, LLC | 3,110,000 | 26.8M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,000,000 | 17.3M $ | as of Mar 31, 2026 |
| AIGH Capital Management LLC | 2,000,000 | 17.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,555,287 | 13.4K $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 1,125,321 | 9.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,005,508 | 8.7M $ | as of Mar 31, 2026 |
| Insight Holdings Group, LLC | 989,054 | 8.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 977,289 | 8.4M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 877,078 | 7.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 845,325 | 7.3M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 721,581 | 6.2M $ | as of Mar 31, 2026 |
| Propel Bio Management, LLC | 644,421 | 5.6M $ | as of Mar 31, 2026 |
| MBB PUBLIC MARKETS I LLC | 614,477 | 5.3M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 605,512 | 5.2M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 577,600 | 5M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | 4.3M $ | as of Mar 31, 2026 |
| UBS Group AG | 449,750 | 3.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 423,826 | 3.7M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 412,032 | 3.6M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 367,492 | 3.2M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 333,692 | 2.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 222,929 | 1.9M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 212,910 | 1.8M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Kyverna Therapeutics Inc". https://titelia.com/en/stocks/kyverna-therapeutics-inc-US5019761049